Although a recent study reported that the cytotoxicity of NK‐1R antagonist aprepitant in human colon cancer cells was mediated by inhibition of the canonical Wnt pathway, the efficacy of aprepitant was independent of the basal Wnt activity,[10a] suggesting that other pathways could be involved. This evidence concerns the gene TACR1 and malignant colon neoplasm.